DVENAFAX 50
Item requires a valid prescription
Manufactured By Steris Healthcare Pvt Ltd
Composition Desvenlafaxine ER 50 mg
Rs 78.09
MRP Rs 111.56
(30% OFF)
Includes all taxes
Package SIZE
( For 10x10 Tablets )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description:
Desvenlafaxine Extended Release 50mg is the active metabolite of venlafaxine, engineered as a standalone medication belonging to the SNRI (serotonin-norepinephrine reuptake inhibitor) antidepressant class. Because it is already the active metabolite, desvenlafaxine offers a more predictable, streamlined pharmacokinetic profile compared to its parent compound, with less dependence on individual liver enzyme metabolism variability between patients.
Under the brand name Dvenafax 50, manufactured by Steris Healthcare, this extended-release formulation is designed to provide smooth, sustained drug levels over 24 hours, supporting stable mood control with convenient once-daily dosing.
Product Information
| Attribute | Detail |
|---|---|
| Brand Name | Dvenafax 50 |
| Composition | Desvenlafaxine Extended Release 50mg |
| Manufacturer/Marketer | Steris Healthcare Pvt. Ltd. |
| Product Form | Tablet (Extended Release) |
| Pack Size | 10x10 Tablets |
| Target Market | India |
| Drug Category | Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) |
| Prescription Status | Schedule H — Prescription Required |
Why It's Important
Major depressive disorder remains one of the most common and disabling mental health conditions worldwide, and India is no exception — with a significant proportion of the population affected at some point in their lives, often without adequate diagnosis or treatment. While SSRIs remain a common first-line treatment choice, a substantial number of patients either do not respond adequately or experience persistent residual symptoms, particularly fatigue, low energy, and difficulty concentrating, even after their mood begins to improve.
This is where desvenlafaxine's clinical importance becomes apparent. As an SNRI, it acts on both serotonin and norepinephrine pathways, offering a broader neurochemical approach to depression treatment than serotonin-selective agents alone. The added noradrenergic activity is particularly relevant for patients whose depression is characterized by prominent fatigue, reduced motivation, and cognitive slowing — symptoms that serotonin-only therapies sometimes address less completely.
Desvenlafaxine's status as venlafaxine's active metabolite also carries practical clinical significance: because it does not require conversion by the liver's CYP2D6 enzyme system, its blood levels tend to be more predictable across different patients, including those with genetic variations in this metabolic pathway. This can translate into more consistent therapeutic response and potentially fewer unpredictable interactions with other CYP2D6-metabolized medications.
The extended-release formulation used in Dvenafax 50 further supports this consistency, delivering steady drug levels over 24 hours and enabling simple, once-daily dosing — a factor strongly associated with improved long-term adherence in chronic conditions like depression, where consistent, uninterrupted treatment is essential to sustained recovery and relapse prevention.
Key Benefits
What Are the Benefits of Dvenafax 50?
Desvenlafaxine Extended Release 50mg, as formulated in Dvenafax 50, offers several clinically meaningful advantages:
- Dual-mechanism antidepressant action: By targeting both serotonin and norepinephrine pathways, desvenlafaxine offers broader neurochemical coverage than serotonin-selective antidepressants alone.
- Effective for fatigue-predominant depression: Its noradrenergic activity can be particularly beneficial for patients whose depression is marked by significant low energy, fatigue, and reduced motivation.
- Predictable pharmacokinetics: As the active metabolite of venlafaxine, desvenlafaxine does not require CYP2D6-dependent liver conversion, supporting more consistent blood levels across different patients.
- Simple, fixed-dose treatment approach: Unlike some antidepressants requiring extensive titration, desvenlafaxine is often used at a standard effective starting dose, simplifying treatment initiation for many patients.
- Smooth, sustained drug delivery: The extended-release formulation provides steady 24-hour blood levels, supporting stable mood control and reducing peak-related side effects.
- Convenient once-daily dosing: This simplifies the treatment regimen for patients managing long-term depression therapy, supporting better adherence over time.
- Alternative for SSRI non-responders: For patients who have not achieved adequate symptom relief with SSRIs, desvenlafaxine offers a valuable next-step option with a different, broader mechanism of action.
- Trusted manufacturing standards: Dvenafax 50 is manufactured by Steris Healthcare, a WHO-GMP and ISO 9001:2018 certified pharmaceutical company, ensuring consistent potency and reliable extended-release performance across every batch.
Side Effects
Common side effects associated with Desvenlafaxine Extended Release include:
- Nausea, particularly during the first one to two weeks of treatment
- Dizziness
- Dry mouth
- Excessive sweating
- Insomnia
- Constipation
- Reduced appetite
- Fatigue in some patients, despite the drug's noradrenergic activity
Most of these effects are mild to moderate and tend to improve over the first few weeks of treatment as the body adjusts to the medication.
Precautions & Warnings
Before starting Dvenafax 50, patients and prescribers should carefully consider the following precautions:
- Blood Pressure: Regular monitoring is recommended, particularly in patients with pre-existing hypertension, given desvenlafaxine's potential to raise blood pressure.
- Suicidal Thoughts: Patients and caregivers should be counseled to monitor for any new or worsening mood changes, depression, or suicidal thinking, particularly during the early months of treatment or after dose changes.
- Renal Impairment: Dose adjustment and closer monitoring are advised in patients with significant kidney dysfunction.
- Hepatic Impairment: Caution is advised in patients with liver dysfunction, and dose adjustment may be considered.
- Glaucoma: Should be used with caution in patients with narrow-angle glaucoma, given the risk of increased intraocular pressure.
- Bleeding Risk: Caution is advised in patients on anticoagulants, antiplatelet agents, or NSAIDs, given desvenlafaxine's potential effect on bleeding tendency.
- Seizure History: Should be used cautiously in patients with a history of seizures.
- Pregnancy and Lactation: Should only be used if clearly necessary and under medical supervision, with careful risk-benefit assessment.
- Drug Interactions: Caution is required when combining with other serotonergic medications (risk of serotonin syndrome), MAO inhibitors (contraindicated), and alcohol, due to additive effects.
Mechanism of Action
Dvenafax 50 exerts its therapeutic effects through selective inhibition of neurotransmitter reuptake in the central nervous system:
- Inhibition of Serotonin Reuptake: Desvenlafaxine blocks the reuptake of serotonin at the presynaptic neuronal membrane, increasing its availability in the synaptic cleft and enhancing serotonergic neurotransmission associated with mood regulation.
- Inhibition of Norepinephrine Reuptake: At therapeutic doses, desvenlafaxine also significantly inhibits norepinephrine reuptake, contributing to improved energy, motivation, and concentration — symptoms often prominent in depressive illness that serotonin-selective agents may address less completely.
- Minimal Dopaminergic Activity: Unlike some other antidepressants, desvenlafaxine has relatively minimal direct effect on dopamine reuptake, distinguishing its receptor profile from certain other antidepressant classes.
- Direct Active Metabolite Status: As the principal active metabolite of venlafaxine, desvenlafaxine does not require hepatic CYP2D6-mediated conversion to become pharmacologically active, resulting in more predictable and consistent drug exposure across patients with varying metabolic enzyme activity.
- Sustained Receptor Engagement: The extended-release formulation ensures consistent receptor engagement over 24 hours, supporting stable mood regulation throughout the day and minimizing the peak-and-trough fluctuations associated with immediate-release formulations.
This dual serotonergic-noradrenergic mechanism, combined with predictable pharmacokinetics, is what distinguishes desvenlafaxine within the broader antidepressant landscape and supports its clinical utility for patients requiring a dual-mechanism approach to depression management.
Frequently Asked Questions (FAQ)
1. Where can I buy Desvenlafaxine 50 mg online?
You can purchase Desvenlafaxine 50 mg through licensed online pharmacies or authorized pharmaceutical suppliers. Verify the manufacturer, strength, batch number, expiry date, and packaging before purchasing.
2. What is the price of Desvenlafaxine 50 mg?
The price may vary depending on the brand, manufacturer, pack size, seller, and applicable pharmacy charges. Check the current listed price before placing an order.
3. Can I order Desvenlafaxine 50 mg online?
Yes, Desvenlafaxine 50 mg can be ordered online where legally available. As it is a prescription medicine, a valid prescription may be required when purchasing it from a licensed pharmacy.
4. Is Desvenlafaxine 50 mg available from Steris Healthcare?
Availability depends on Steris Healthcare's current product range and stock status. Contact Steris Healthcare or an authorized distributor to confirm availability, strength, pack size, and ordering details.
5. What is Desvenlafaxine 50 mg used for?
Desvenlafaxine 50 mg is an antidepressant belonging to the serotonin-norepinephrine reuptake inhibitor (SNRI) class. It is primarily used to treat major depressive disorder (MDD) in adults. Use it only under the supervision of a qualified healthcare professional.
6. What is the composition of Desvenlafaxine 50 mg?
Desvenlafaxine 50 mg contains Desvenlafaxine 50 mg as the active pharmaceutical ingredient. The inactive ingredients may vary depending on the manufacturer and formulation.
7. Is a prescription required?
Yes, Desvenlafaxine is generally a prescription medicine and should be used under medical supervision. Follow the prescription and dosage instructions provided by your healthcare professional.
8. How should Desvenlafaxine 50 mg be taken?
Take Desvenlafaxine 50 mg exactly as prescribed by your doctor. It is commonly taken once daily, with or without food, at approximately the same time each day. Swallow the tablet whole unless your doctor provides different instructions. Do not suddenly stop treatment without medical advice.
9. What should I know before buying Desvenlafaxine 50 mg?
Before purchasing, verify the strength, manufacturer, batch number, expiry date, packaging, and storage instructions. Tell your healthcare professional about other medicines or supplements you take and any relevant medical conditions. Desvenlafaxine may interact with certain medicines, including MAO inhibitors and other serotonergic medicines.
10. How can I order Desvenlafaxine 50 mg online?
Order Desvenlafaxine 50 mg through a licensed online pharmacy or authorized pharmaceutical supplier. Provide a valid prescription if required, select the prescribed strength and pack size, and verify the product, manufacturer, expiry date, and delivery details before completing your order.